![](https://endpts.com/wp-content/uploads/2022/02/Richard-Pazdur-Flatiron-Health-via-YouTube-scaled.jpg)
Richard Pazdur, FDA's OCE director (Flatiron Health via YouTube)
FDA's cancer chief weighs in on common chemo shortages — report
Richard Pazdur, director of the FDA’s Oncology Center of Excellence, attributes the current shortage of two cancer drugs to drug companies that haven’t invested in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.